Tag: gene
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product
By Claude Leguilloux Published on 07/10/2023 at 07:46 (Boursier.com) — Sensorion a pioneering clinical-stage biotechnology company dedicated…
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product – 7/10/2023 at 07:30
Sensorion submits an application for clinical trial authorization, in the UK, for OTOF-GT, its most advanced gene therapy product. Montpellier, July 10, 2023 at 7:30 a.m. CET – Sensorion (FR0012596468…
Neurodevelopmental disorders in children: a new gene implicated
Yasmina Kattou, edited by Corentin Alloune / Photo credit 12:45 p.m., July 02, 2023 Research in childhood neurodevelopment is progressing. Work has been published in Science Translational Medicine where a…
Paris 2024 Olympics: is gene doping a threat to the sports community?
Axel May / Photo credit: MUSTAFA YALCIN / ANADOLU AGENCY / Anadolu Agency via AFP 10:56 a.m., April 15, 2023 The sports authorities held their annual conference in Paris on…
KISS bassist Gene Simmons: After a fainting spell, he continues to play while sitting
KISS bassist Gene Simmons After a fainting spell, he continues to play while sitting KISS’ Gene Simmons in top form on stage. © Tony Norkus/Shutterstock.com During KISS farewell tour: Gene…
KISS bassist Gene Simmons faints on stage
KISS bassist Gene Simmons weakness on stage KISS’ Gene Simmons in top form on stage. © Tony Norkus/Shutterstock.com During KISS farewell tour: Gene Simmons suffers a dizzy spell on stage…
Sensorion organizes an R&D day dedicated to its gene therapy programs – 02/21/2023 at 07:30
Sensorion organizes an R&D day dedicated to its gene therapy programs Make a date – Thursday April 6, 2023 at 2 p.m. CEST Montpellier, February 21, 2023 – Sensorion (FR0012596468…
Sensorion and EVEON collaborate on the development of an injection system for the administration of gene therapy treatments in the inner ear – 01/31/2023 at 07:30
1/2 Sensorion and EVEON collaborate on the development of an injection system for delivering gene therapy treatments to the inner ear Montpellier, January 31, 2023 – Sensorion (FR0012596468 – ALSEN),…
Gene therapy: GenSight Biologics raises 12 million euros from an American fund – 12/23/2022 at 10:17
(AOF) – GenSight Biologics, a biopharmaceutical company dedicated to the development and commercialization of gene therapies for neurodegenerative diseases of the retina and central nervous system, announces that it has…
Lysogene Announces Positive DSMB Findings Recommending Study Continuation and Positive Biomarker Data in Phase 1 of Adaptive Gene Therapy Clinical Trial with LYS-GM101 for the Treatment of GM1 Gangliosidosis – 11/29/ 2022 at 6:00 PM
• Finalization of the treatment and follow-up at 6 months of the last patient recruited in the first phase of the adaptive clinical trial P1-GM-101 • The DSMB gave a…
Sensorion Receives Rare Pediatric Disease Designation from the US Food and Drug Administration for the treatment of hearing loss related to the otoferlin gene – 11/07/2022 at 07:30
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, announces that the U.S. Food and Drug Administration (FDA)…
Pfizer: recruiting for gene therapy
(CercleFinance.com) – Pfizer and Sangamo Therapeutics have announced the reopening of recruitment for the AFFINE phase 3 study evaluating giroctocogene fitelparvovec, an experimental gene therapy for patients with moderately severe…